Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ALXOALX ONCOLOGY HOLDINGS INC

Nasdaq · CIK 0001810182
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts309

Identity from submissions API

NameALX ONCOLOGY HOLDINGS INC
CIK0001810182
TickersALXO
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN850642577
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone650-466-7125
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
323 ALLERTON AVENUE
SOUTH SAN FRANCISCO
CA
94080
CA
Mailing address
323 ALLERTON AVENUE
SOUTH SAN FRANCISCO
CA
94080
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

424 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-19 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-130295 005-91585 261576380 34 24110
2026-11-16 10-Q 10-Q 0001193125-26-462197 001-39386 261555613 34 11929105 1 1
2026-11-16 8-K 8-K 2.02,9.01 0001193125-26-462188 001-39386 261555592 34 459337 1 1
2026-10-16 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0000905148-26-004485 005-91585 261467356 34 34547
2026-10-15 8-K 8-K 1.01,3.02,9.01 0001193125-26-422992 001-39386 261463566 34 460484 1 1
2026-08-18 4 4 0001193125-26-355764 4957
2026-08-18 4 4 0001193125-26-355761 4835
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-352359 005-91585 261282261 34 18524
2026-08-06 10-Q 10-Q 0001193125-26-337920 001-39386 261248710 34 12426607 1 1
2026-08-06 8-K 8-K 2.02,9.01 0001193125-26-336843 001-39386 261246137 34 431702 1 1
2026-07-27 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002155 005-91585 261206052 34 10780
2026-07-06 4 4 0001193125-26-296246 5485
2026-06-30 8-K 8-K 5.02,7.01,8.01,9.01 0001193125-26-290447 001-39386 261140413 34 223224 1 1
2026-06-26 8-K 8-K 1.01,1.02,2.03,9.01 0001193125-26-285425 001-39386 261128937 34 170590 1 1
2026-06-11 8-K 8-K 5.07 0001193125-26-267472 001-39386 261082960 34 194589 1 1
2026-05-27 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001643828-26-000002 005-91585 261026417 34 18669
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-062566 005-91585 26987755 34 13347
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-062512 005-91585 26987069 34 7976
2026-05-08 10-Q 10-Q 0001193125-26-213399 001-39386 26956167 34 9871031 1 1
2026-05-08 8-K 8-K 2.02,9.01 0001193125-26-213380 001-39386 26956146 34 356711 1 1
2026-04-28 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-050505 005-91585 26909484 34 18333
2026-04-20 ARS ARS 0001193125-26-164310 001-39386 26876074 34 6965550
2026-04-20 DEF 14A DEF 14A 0001193125-26-163936 001-39386 26875048 34 10585111 1 1
2026-04-17 4 4 0001193125-26-161558 5358
2026-04-17 4 4 0001193125-26-161557 5339
2026-04-17 3 3 0001193125-26-161540 12250
2026-04-13 8-K 8-K 5.02,7.01,9.01 0001193125-26-152050 001-39386 26856553 34 222411 1 1
2026-03-23 4 4 0001193125-26-119705 4799
2026-03-23 4 4 0001193125-26-119703 4768
2026-03-09 10-K 10-K 0001193125-26-098454 001-39386 26734837 34 27666827 1 1
2026-03-05 4 4 0001193125-26-093913 5203
2026-03-05 3 3 0001193125-26-093894 16887
2026-02-27 8-K 8-K 2.02,9.01 0001193125-26-079342 001-39386 26692740 34 429762 1 1
2026-02-20 4 4 0001193125-26-061313 4614
2026-02-19 4 4 0001193125-26-060037 4826
2026-02-09 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001346824-26-000010 005-91585 26612337 34 19790
2026-02-06 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-26-041306 005-91585 26608347 34 138462
2026-02-04 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000905148-26-000512 005-91585 26600083 34 15854
2026-02-04 4 xslF345X05/form4-02042026_090252.xml 0001278411-26-000002 9280
2026-01-30 424B5 424B5 0001193125-26-031754 333-285620 26583292 33 476051
2026-01-30 8-K 8-K 1.01,8.01,9.01 0001193125-26-030579 001-39386 26580644 34 625149 1 1
2026-01-30 8-K 8-K 8.01,9.01 0001193125-26-030561 001-39386 26580612 34 162344 1 1
2026-01-28 4 4 0001193125-26-027290 5161
2026-01-28 4 4 0001193125-26-027288 5181
2026-01-28 4 4 0001193125-26-027287 5209
2026-01-21 S-8 S-8 0001193125-26-018159 333-292860 26548840 33 831230 1 1
2026-01-21 8-K 8-K 5.02,9.01 0001193125-26-018094 001-39386 26548475 34 705068 1 1
2026-01-21 4 4 0001193125-26-018039 5115
2026-01-21 4 4 0001193125-26-018037 5106
2026-01-21 4 4 0001193125-26-018028 5144
2026-01-21 4 4 0001193125-26-018023 5115
2026-01-21 4 4 0001193125-26-018022 5143
2026-01-21 4 4 0001193125-26-018021 5092
2026-01-07 4 4 0001193125-26-006374 5272
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001214659-25-016686 005-91585 251486560 34 13286
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001214659-25-016679 005-91585 251486436 34 13286
2025-11-07 10-Q 10-Q 0001193125-25-272281 001-39386 251462479 34 10610052 1 1
2025-11-07 8-K 8-K 2.02,9.01 0001193125-25-271112 001-39386 251460619 34 589107 1 1
2025-10-22 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-101541 005-91585 251410425 34 18173
2025-10-16 4 4 0001193125-25-241382 5230
2025-10-16 4 4 0001193125-25-241381 5258
2025-10-16 4 4 0001193125-25-241380 5210
2025-10-08 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-097929 005-91585 251382507 34 15498
2025-09-19 4 4 0001193125-25-209045 5208
2025-09-18 4 4 0001193125-25-207432 6593
2025-09-12 8-K 8-K 5.02,8.01,9.01 0001810182-25-000006 001-39386 251310104 34 401421 1 1
2025-08-20 4 4 0000950170-25-110434 4874
2025-08-19 4 4 0000950170-25-110102 5229
2025-08-19 4 4 0000950170-25-110099 5295
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-078632 005-91585 251219438 34 14155
2025-08-13 4 4 0000950170-25-108119 5176
2025-08-13 3 3 0000950170-25-108058 11803
2025-08-12 10-Q 10-Q 0000950170-25-107303 001-39386 251206694 34 10488036 1 1
2025-08-12 8-K 8-K 2.02,5.02,8.01,9.01 0000950170-25-107277 001-39386 251206521 34 600172 1 1
2025-07-08 4 4 0000950170-25-094613 5054
2025-07-01 4 4 0000950170-25-092232 4575
2025-06-12 8-K 8-K 5.07 0000950170-25-085364 001-39386 251042796 34 173119 1 1
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001214659-25-007868 005-91585 25953328 34 29867
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-049410 005-91585 25952662 34 7821
2025-05-08 10-Q 10-Q 0000950170-25-066894 001-39386 25925810 34 9475825 1 1
2025-05-08 8-K 8-K 2.02 0000950170-25-066440 001-39386 25924061 34 529298 1 1
2025-04-25 8-K 8-K 3.01 0000950170-25-058687 001-39386 25873630 34 161691 1 1
2025-04-24 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001231 333-285620 25869708 33 1733
2025-04-23 CORRESP filename1.htm 0001193125-25-091436 18305
2025-04-21 ARS ARS 0000950170-25-056386 001-39386 25854415 34 5516394
2025-04-21 DEF 14A DEF 14A 0000950170-25-056291 001-39386 25853231 34 5320250 1 1
2025-04-15 4 xslF345X05/form4-04152025_080416.xml 0001415889-25-010697 5292
2025-04-15 4 xslF345X05/form4-04152025_080430.xml 0001415889-25-010692 5354
2025-04-15 4 xslF345X05/form4-04152025_080423.xml 0001415889-25-010690 5315
2025-04-15 4 xslF345X05/form4-04152025_080459.xml 0001415889-25-010686 5359
2025-03-18 4 xslF345X05/form4-03182025_080356.xml 0001415889-25-008428 4873
2025-03-18 4 xslF345X05/form4-03182025_080326.xml 0001415889-25-008417 4939
2025-03-11 UPLOAD filename1.pdf 0000000000-25-002662 333-285620 40076
2025-03-06 S-3 S-3 0001193125-25-048564 333-285620 25716463 33 408466
2025-03-06 10-K 10-K 0000950170-25-034761 001-39386 25715783 34 20891826 1 1
2025-03-06 8-K 8-K 2.02,9.01 0000950170-25-034574 001-39386 25715090 34 572696 1 1
2025-03-05 8-K 8-K 2.05,5.02 0000950170-25-033504 001-39386 25710785 34 167551 1 1
2025-02-21 4 xslF345X05/form4-02212025_090224.xml 0001415889-25-005071 5234
2025-02-21 4 xslF345X05/form4-02212025_090208.xml 0001415889-25-005069 9165
2025-02-21 4 xslF345X05/form4-02212025_090215.xml 0001415889-25-005067 5469
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001214659-25-002805 005-91585 25627868 34 24963
2025-01-23 4 xslF345X05/form4-01232025_110145.xml 0001415889-25-001983 9268
2025-01-23 4 xslF345X05/form4-01232025_110148.xml 0001415889-25-001981 9250
2025-01-23 4 xslF345X05/form4-01232025_110113.xml 0001415889-25-001979 9285
2025-01-23 4 xslF345X05/form4-01232025_110135.xml 0001415889-25-001977 5373
2025-01-23 3 xslF345X02/form3-01232025_110142.xml 0001415889-25-001975 7134
2025-01-23 4 xslF345X05/form4-01232025_110125.xml 0001415889-25-001973 5373
2025-01-23 3 xslF345X02/form3-01232025_110117.xml 0001415889-25-001971 8697
2025-01-23 4 xslF345X05/form4-01232025_110129.xml 0001415889-25-001969 5378
2025-01-23 3 xslF345X02/form3-01232025_110134.xml 0001415889-25-001967 7093
2025-01-23 4 xslF345X05/form4-01232025_110113.xml 0001415889-25-001965 9279
2025-01-23 4 xslF345X05/form4-01232025_110146.xml 0001415889-25-001963 9352
2025-01-23 4 xslF345X05/form4-01232025_110133.xml 0001415889-25-001961 9397
2025-01-23 4 xslF345X05/form4-01232025_110159.xml 0001415889-25-001959 9338
2025-01-22 8-K 8-K 5.02,7.01,8.01,9.01 0000950170-25-007532 001-39386 25543931 34 247649 1 1
2025-01-17 8-K 8-K 5.02,9.01 0001193125-25-008461 001-39386 25539216 34 412957 1 1
2025-01-17 S-8 S-8 0001193125-25-008459 333-284348 25539197 33 311331
2025-01-08 4 xslF345X05/form4-01082025_090144.xml 0001415889-25-001120 5224
2025-01-02 4 xslF345X05/form4-01022025_090133.xml 0001415889-25-000132 5226
2025-01-02 4 xslF345X05/form4-01022025_090125.xml 0001415889-25-000123 9166
2024-12-31 SC TO-I/A SC TO-I/A 0001193125-24-287178 005-91585 241593155 34 16882
2024-12-27 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-24-132130 005-91585 241585746 34 7692
2024-12-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-24-002979 005-91585 241531184 34 11380
2024-12-04 4 xslF345X05/form4-12042024_091224.xml 0001415889-24-028247 8966
2024-12-04 4 xslF345X05/form4-12042024_091224.xml 0001415889-24-028245 9186
2024-12-04 4 xslF345X05/form4-12042024_091258.xml 0001415889-24-028239 9261
2024-12-02 SC TO-I SC TO-I 0001193125-24-268885 005-91585 241519051 34 590652
2024-11-19 4 xslF345X05/form4-11192024_091142.xml 0001415889-24-027181 9309
2024-11-14 SC 13G/A AMENDMENT NO. 2 0000947871-24-000917 005-91585 241465197 34 60282
2024-11-14 SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0001213900-24-098623 005-91585 241465115 34 111218
2024-11-14 SC 13G/A cormorant-alxo093024a1.htm 0001172661-24-005042 005-91585 241460722 34 87664
2024-11-14 8-K 8-K 5.02,7.01,8.01,9.01 0000950170-24-126749 001-39386 241457307 34 399470 1 1
2024-11-12 SC 13G/A filing.txt 0000315066-24-002680 005-91585 241444444 34 8148
2024-11-07 10-Q 10-Q 0000950170-24-123290 001-39386 241435570 34 8780797 1 1
2024-11-07 8-K 8-K 2.02,5.02,9.01 0000950170-24-123252 001-39386 241435436 34 527016 1 1
2024-10-10 SC 13G/A ALXO_SC13GA1.htm 0001273087-24-000097 005-91585 241365374 34 81831
2024-10-04 8-K 8-K 5.02,9.01 0000950170-24-112734 001-39386 241353646 34 164977 1 1
2024-08-22 SC 13G s815246sc13g.htm 0001214659-24-015149 005-91585 241231921 34 85305
2024-08-16 4 xslF345X05/form4-08162024_090836.xml 0001415889-24-021482 4778
2024-08-16 4 xslF345X05/form4-08162024_090823.xml 0001415889-24-021480 4831
2024-08-16 4 xslF345X05/form4-08162024_090807.xml 0001415889-24-021476 4806
2024-08-16 4 xslF345X05/form4-08162024_090846.xml 0001415889-24-021474 4819
2024-08-16 4 xslF345X05/form4-08162024_090831.xml 0001415889-24-021471 4824
2024-08-13 SC 13G ALXO_SC13G.htm 0001273087-24-000083 005-91585 241201732 34 81786
2024-08-12 10-Q 10-Q 0000950170-24-095391 001-39386 241196673 34 8411622 1 1
2024-08-08 8-K 8-K 2.02,9.01 0000950170-24-093930 001-39386 241188302 34 527065 1 1
2024-08-07 4 xslF345X05/form4-08072024_090845.xml 0001415889-24-020932 5363
2024-08-07 3 xslF345X02/form3-08072024_090832.xml 0001415889-24-020930 7044
2024-08-06 8-K 8-K 5.02,8.01,9.01 0000950170-24-091938 001-39386 241180072 34 401192 1 1
2024-07-15 4 xslF345X05/form4-07152024_080721.xml 0001415889-24-019546 9016
2024-07-11 144 xsl144X01/primary_doc.xml 0001974158-24-000050 001-39386 241112308 33 6887
2024-07-09 4 xslF345X05/form4-07092024_080737.xml 0001415889-24-019429 5258
2024-07-03 4 xslF345X05/form4-07032024_090722.xml 0001415889-24-019228 5434
2024-07-03 4 xslF345X05/form4-07032024_090700.xml 0001415889-24-019224 5309
2024-07-03 4 xslF345X05/form4-07032024_090724.xml 0001415889-24-019221 5298
2024-07-02 4 xslF345X05/form4-07022024_080741.xml 0001415889-24-018919 4983
2024-06-24 4/A xslF345X05/form4a-06242024_010651.xml 0001415889-24-017899 5846
2024-06-17 8-K 8-K 5.07 0000950170-24-074258 001-39386 241048567 34 171865 1 1
2024-06-17 4 xslF345X05/form4-06172024_110650.xml 0001415889-24-017054 5081
2024-06-14 4 xslF345X05/form4-06142024_080638.xml 0001415889-24-016955 5415
2024-06-14 4 xslF345X05/form4-06142024_080642.xml 0001415889-24-016952 5399
2024-06-14 4 xslF345X05/form4-06142024_080636.xml 0001415889-24-016949 5438
2024-06-06 4 xslF345X05/form4-06062024_080618.xml 0001415889-24-015737 9016
2024-06-04 144 xsl144X01/primary_doc.xml 0001974158-24-000043 001-39386 241018174 33 6337
2024-05-15 4 xslF345X05/form4-05152024_080510.xml 0001415889-24-013237 7135
2024-05-13 144 xsl144X01/primary_doc.xml 0001974158-24-000037 001-39386 24939034 33 4561
2024-05-09 10-Q 10-Q 0000950170-24-056953 001-39386 24930677 34 7392314 1 1
2024-05-09 8-K 8-K 2.02,9.01 0000950170-24-056886 001-39386 24930424 34 481639 1 1
2024-05-08 4 xslF345X05/form4-05082024_090502.xml 0001415889-24-012637 9020
2024-05-06 144 xsl144X01/primary_doc.xml 0001974158-24-000035 001-39386 24917416 33 5734
2024-05-02 DEFA14A DEFA14A 0000950170-24-052106 001-39386 24908282 34 54546
2024-05-02 8-K 8-K 5.02 0000950170-24-052093 001-39386 24908202 34 162200 1 1
2024-04-23 ARS ARS 0000950170-24-046549 001-39386 24862296 34 5101425
2024-04-22 DEF 14A DEF 14A 0000950170-24-046410 001-39386 24861118 34 1844030
2024-04-18 4 xslF345X05/form4-04182024_080417.xml 0001415889-24-011128 9018
2024-04-16 144 xsl144X01/primary_doc.xml 0001974158-24-000032 001-39386 24848237 33 6215
2024-04-05 4 xslF345X05/form4-04052024_090425.xml 0001415889-24-010443 5298
2024-04-04 144 xsl144X01/primary_doc.xml 0001974158-24-000019 001-39386 24823610 33 5132
2024-03-18 4 xslF345X05/form4-03182024_080318.xml 0001415889-24-008260 4606
2024-03-08 S-8 S-8 0001193125-24-062539 333-277765 24731997 33 85398
2024-03-07 10-K 10-K 0000950170-24-027955 001-39386 24730210 34 14917152 1 1
2024-03-07 8-K 8-K 2.02,9.01 0000950170-24-027925 001-39386 24730031 34 529598 1 1
2024-02-16 4 xslF345X05/form4-02162024_110202.xml 0001415889-24-004233 7059
2024-02-16 4 xslF345X05/form4-02162024_110247.xml 0001415889-24-004231 7085
2024-02-16 4 xslF345X05/form4-02162024_110240.xml 0001415889-24-004227 7110
2024-02-16 4 xslF345X05/form4-02162024_110225.xml 0001415889-24-004218 7098
2024-02-16 4 xslF345X05/form4-02162024_110246.xml 0001415889-24-004210 7090
2024-02-14 SC 13G/A AMENDMENT NO. 1 0000947871-24-000163 005-91585 24641527 34 59757
2024-02-14 SC 13D/A SC 13D/A 0001104659-24-024164 005-91585 24641486 34 311227
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-023769 005-91585 24638938 34 106949
2024-02-09 SC 13G/A filing.txt 0000315066-24-001014 005-91585 24611331 34 8175
2024-01-05 4 FORM 4 SUBMISSION 0001209191-24-000985 5312
2024-01-03 4 FORM 4 SUBMISSION 0001209191-24-000379 5012
2024-01-03 4 FORM 4 SUBMISSION 0001209191-24-000374 4884
2024-01-03 4 FORM 4 SUBMISSION 0001209191-24-000366 5035
2024-01-03 4 FORM 4 SUBMISSION 0001209191-24-000359 4872
2023-12-26 8-K 8-K 1.01,2.03,9.01 0000950170-23-073016 001-39386 231513314 34 270226 1 1
2023-12-20 SC 13D/A SC 13D/A 0001104659-23-127396 005-91585 231498683 34 189990
2023-11-13 10-Q 10-Q 0000950170-23-062929 001-39386 231398724 34 9313419 1 1
2023-11-13 8-K 8-K 2.02,9.01 0000950170-23-062903 001-39386 231398499 34 595391 1 1
2023-10-16 SC 13G SC 13G 0001104659-23-109411 005-91585 231327929 34 92629
2023-10-13 SC 13G schedule13g.htm 0000929638-23-002776 005-91585 231325067 34 126989
2023-10-06 8-K 8-K 1.01,8.01,9.01 0001193125-23-251917 001-39386 231312540 34 616411 1 1
2023-10-06 424B5 424B5 0001193125-23-251913 333-263863 231312532 33 461123
2023-10-04 8-K 8-K 2.02 0001193125-23-250822 001-39386 231308966 34 142331 1 1
2023-10-04 424B5 424B5 0001193125-23-250821 333-263863 231308960 33 459213
2023-10-04 8-K 8-K 8.01,9.01 0001193125-23-250357 001-39386 231306592 34 180648 1 1
2023-09-12 4 FORM 4 SUBMISSION 0001209191-23-049102 5398
2023-09-08 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-09-08 16:05:00 9999999995-23-002617 333-274314 231246551 33 1692
2023-09-08 424B3 424B3 0001193125-23-231576 333-274314 231245616 33 184523
2023-09-07 CORRESP filename1.htm 0001193125-23-230125 19451
2023-09-06 UPLOAD filename1.pdf 0000000000-23-009863 40221
2023-09-06 8-K 8-K 5.02,7.01,8.01,9.01 0001193125-23-229584 001-39386 231239166 34 246364 1 1
2023-09-01 S-3 S-3 0001193125-23-227645 333-274314 231232644 33 275514
2023-08-25 424B5 424B5 0001193125-23-221567 333-263863 231208996 33 12074
2023-08-10 10-Q 10-Q 0000950170-23-041319 001-39386 231159414 34 10031940 1 1
2023-08-10 8-K 8-K 2.02,9.01 0000950170-23-041287 001-39386 231159228 34 626819 1 1
2023-07-27 4 FORM 4 SUBMISSION 0001209191-23-043531 7122
2023-07-27 4 FORM 4 SUBMISSION 0001209191-23-043523 7131
2023-07-27 4 FORM 4 SUBMISSION 0001209191-23-043519 7159
2023-07-27 4 FORM 4 SUBMISSION 0001209191-23-043514 7174
2023-07-07 4 FORM 4 SUBMISSION 0001209191-23-041790 4749
2023-07-05 4 FORM 4 SUBMISSION 0001209191-23-041204 4801
2023-07-05 4 FORM 4 SUBMISSION 0001209191-23-041197 4790
2023-07-05 4 FORM 4 SUBMISSION 0001209191-23-041189 4924
2023-07-05 4 FORM 4 SUBMISSION 0001209191-23-041175 4950
2023-06-22 4 FORM 4 SUBMISSION 0001209191-23-039109 5367
2023-06-22 4 FORM 4 SUBMISSION 0001209191-23-039103 5389
2023-06-22 4 FORM 4 SUBMISSION 0001209191-23-039096 5341
2023-06-22 4 FORM 4 SUBMISSION 0001209191-23-039082 5365
2023-06-22 4 FORM 4 SUBMISSION 0001209191-23-039072 5325
2023-06-22 4 FORM 4 SUBMISSION 0001209191-23-039063 5398
2023-06-20 8-K 8-K 5.03,5.07,9.01 0000950170-23-028787 001-39386 231023518 34 632113 1 1
2023-06-13 4 FORM 4 SUBMISSION 0001209191-23-036733 14780
2023-05-11 10-Q 10-Q 0000950170-23-021247 001-39386 23911151 34 9204478 1 1
2023-05-11 8-K 8-K 2.02,9.01 0000950170-23-021199 001-39386 23910851 34 542936 1 1
2023-04-24 ARS ARS 0000950170-23-013956 001-39386 23838048 34 6608611
2023-04-24 DEF 14A DEF 14A 0000950170-23-013952 001-39386 23838038 34 1903783
2023-03-13 8-K 8-K 7.01 0001193125-23-068511 001-39386 23725772 34 142838 1 1
2023-03-09 S-8 S-8 0001193125-23-066246 333-270424 23720553 33 85204
2023-03-09 10-K 10-K 0000950170-23-007013 001-39386 23719775 34 19788693 1 1
2023-03-09 8-K 8-K 2.02,9.01 0000950170-23-006999 001-39386 23719672 34 627764 1 1
2023-02-14 SC 13G SCHEDULE 13G 0000947871-23-000164 005-91585 23628953 34 57566
2023-02-09 SC 13G/A filing.txt 0000315066-23-001394 005-91585 23601285 34 8093
2023-01-03 4 FORM 4 SUBMISSION 0001209191-23-000485 5415
2023-01-03 4 FORM 4 SUBMISSION 0001209191-23-000483 5250
2023-01-03 4 FORM 4 SUBMISSION 0001209191-23-000475 5441
2023-01-03 4 FORM 4 SUBMISSION 0001209191-23-000472 5239
2022-12-20 4 FORM 4 SUBMISSION 0001209191-22-062178 14731
2022-11-29 4 FORM 4 SUBMISSION 0001209191-22-058946 5202
2022-11-29 3 FORM 3 SUBMISSION 0001209191-22-058943 5026
2022-11-29 8-K 8-K 5.02 0000950170-22-025765 001-39386 221428743 34 409546 1 1
2022-11-08 10-Q 10-Q 0000950170-22-023237 001-39386 221369155 34 9453621 1 1
2022-11-08 8-K 8-K 2.02 0000950170-22-023194 001-39386 221368804 34 608243 1 1
2022-10-31 8-K 8-K 1.01,2.03,9.01 0000950170-22-020521 001-39386 221343796 34 1302928 1 1
2022-08-10 SC 13G/A filing.txt 0000315066-22-001697 005-91585 221150486 34 7903
2022-08-09 4 FORM 4 SUBMISSION 0001209191-22-045067 7155
2022-08-09 4 FORM 4 SUBMISSION 0001209191-22-045064 7275
2022-08-09 4 FORM 4 SUBMISSION 0001209191-22-045056 7301
2022-08-09 4 FORM 4 SUBMISSION 0001209191-22-045054 7143
2022-08-08 10-Q 10-Q 0000950170-22-015553 001-39386 221144714 34 8623106 1 1
2022-08-08 8-K 8-K 2.02,9.01 0000950170-22-015504 001-39386 221144264 34 587287 1 1
2022-06-16 4 FORM 4 SUBMISSION 0001209191-22-037677 5353
2022-06-16 4 FORM 4 SUBMISSION 0001209191-22-037649 5381
2022-06-16 4 FORM 4 SUBMISSION 0001209191-22-037645 5375
2022-06-16 4 FORM 4 SUBMISSION 0001209191-22-037643 5326
2022-06-16 4 FORM 4 SUBMISSION 0001209191-22-037634 5351
2022-06-16 8-K 8-K 5.07 0001193125-22-175515 001-39386 221020740 34 151456 1 1
2022-06-10 SC 13G/A SEC SCHEDULE 13G 0000902219-22-000039 005-91585 221007896 34 32869
2022-05-31 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-22-162411,2022-05-31 9999999995-22-001634 333-258812 22985818 33 1704
2022-05-27 POS AM POS AM 0001193125-22-162411 333-258812 22978225 33 18979
2022-05-25 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-05-25 16:05:00 9999999995-22-001588 333-263863 22965392 33 1691
2022-05-24 CORRESP filename1.htm 0001193125-22-158660 21761
2022-05-13 S-3/A S-3/A 0001193125-22-150235 333-263863 22923847 33 479318
2022-05-09 10-Q 10-Q 0000950170-22-008499 001-39386 22905115 34 8140114 1 1
2022-05-09 8-K 8-K 2.02,9.01 0000950170-22-008477 001-39386 22904834 34 327616 1 1
2022-04-22 DEF 14A DEF 14A 0000950170-22-005982 001-39386 22843503 34 2126479
2022-04-14 4 FORM 4 SUBMISSION 0001209191-22-024484 5269
2022-04-14 3 FORM 3 SUBMISSION 0001209191-22-024481 5077
2022-04-12 8-K 8-K 5.02 0000950170-22-005597 001-39386 22821159 34 208694 1 1
2022-03-29 UPLOAD filename1.pdf 0000000000-22-003369 40175
2022-03-25 S-3 S-3 0001193125-22-085234 333-263863 22771996 33 605624
2022-02-28 S-8 S-8 0001564590-22-007643 333-263090 22690387 33 194316
2022-02-28 10-K 10-K 0001564590-22-007364 001-39386 22683949 34 20304960 1 1
2022-02-28 8-K Q4'21 8-K/PR 2.02,9.01 0001564590-22-007361 001-39386 22683939 34 494854 1 1
2022-02-09 SC 13G filing.txt 0000315066-22-000772 005-91585 22604119 34 8388
2022-02-08 4 FORM 4 SUBMISSION 0001209191-22-007887 12531
2022-02-07 4 FORM 4 SUBMISSION 0001209191-22-007348 10985
2022-02-04 SC 13G/A SEC SCHEDULE 13G 0001678858-22-000096 005-91585 22591237 34 37666
2022-02-01 4 FORM 4 SUBMISSION 0001209191-22-005923 4981
2021-12-17 8-K 8-K 1.01,9.01 0001193125-21-361275 001-39386 211502361 34 468429 1 1
2021-12-17 424B5 424B5 0001193125-21-361264 333-258812 211502350 33 405802
2021-12-16 4 FORM 4 SUBMISSION 0001209191-21-070094 10797
2021-12-15 4 FORM 4 SUBMISSION 0000899243-21-048463 30309
2021-12-15 4 FORM 4 SUBMISSION 0001209191-21-069867 43907
2021-12-10 4 FORM 4 SUBMISSION 0001209191-21-069154 37587
2021-12-10 4 FORM 4 SUBMISSION 0001209191-21-069135 51301
2021-11-23 4 FORM 4 SUBMISSION 0001209191-21-066436 8999
2021-11-12 10-Q Q3'21 10-Q 0001564590-21-056516 001-39386 211400049 34 8218614 1 1
2021-11-12 8-K Q3'21 8-K 2.02,9.01 0001564590-21-056507 001-39386 211399896 34 474564 1 1
2021-10-20 4 FORM 4 SUBMISSION 0001209191-21-061198 7111
2021-10-20 4 FORM 4 SUBMISSION 0001209191-21-061195 7111
2021-10-19 4 FORM 4 SUBMISSION 0001209191-21-060910 19781
2021-10-12 4 FORM 4 SUBMISSION 0001209191-21-060229 7123
2021-10-07 8-K SCALMIBIO ACQUISITION 3.02,8.01,9.01 0001564590-21-050370 001-39386 211311063 34 272192 1 1
2021-09-21 4 FORM 4 SUBMISSION 0001209191-21-057033 10722
2021-09-17 4 FORM 4 SUBMISSION 0001209191-21-056787 23247
2021-09-13 4 FORM 4 SUBMISSION 0001209191-21-055753 8928
2021-09-10 SC 13G SEC SCHEDULE 13G 0000902219-21-000387 005-91585 211245954 34 37893
2021-08-27 8-K 8-K 5.02 0001564590-21-046136 001-39386 211219926 34 167747 1 1
2021-08-24 4 FORM 4 SUBMISSION 0001209191-21-053218 24359
2021-08-20 4 FORM 4 SUBMISSION 0001209191-21-052864 16315
2021-08-18 4 FORM 4 SUBMISSION 0001209191-21-052397 17917
2021-08-13 S-3ASR S-3ASR 0001193125-21-246134 333-258812 211172685 33 237269
2021-08-12 10-Q 10-Q 0001564590-21-044024 001-39386 211168279 34 7561019 1 1
2021-08-12 8-K 8-K 2.02,9.01 0001564590-21-043991 001-39386 211167826 34 476421 1 1
2021-08-11 4 FORM 4 SUBMISSION 0001209191-21-050823 8683
2021-08-03 4 FORM 4 SUBMISSION 0001209191-21-049415 5288
2021-08-03 4 FORM 4 SUBMISSION 0001209191-21-049408 5343
2021-08-03 4 FORM 4 SUBMISSION 0001209191-21-049398 5313
2021-08-03 4 FORM 4 SUBMISSION 0001209191-21-049385 5331
2021-07-20 4 FORM 4 SUBMISSION 0001209191-21-047365 8916
2021-07-14 4 FORM 4 SUBMISSION 0001209191-21-046679 7120
2021-06-22 4 FORM 4 SUBMISSION 0001209191-21-042395 7110
2021-06-15 4 FORM 4 SUBMISSION 0001209191-21-040738 5571
2021-06-15 4 FORM 4 SUBMISSION 0001209191-21-040732 5352
2021-06-15 4 FORM 4 SUBMISSION 0001209191-21-040728 5374
2021-06-15 4 FORM 4 SUBMISSION 0001209191-21-040725 5325
2021-06-15 4 FORM 4 SUBMISSION 0001209191-21-040722 5350
2021-06-15 8-K 8-K 5.07 0001564590-21-033029 001-39386 211019498 34 42479
2021-06-15 SC 13D/A alx13da2.htm 0000935836-21-000389 005-91585 211017496 34 92173
2021-06-14 4 FORM 4 SUBMISSION 0001209191-21-040221 8927
2021-05-20 4 FORM 4 SUBMISSION 0001209191-21-034662 8915
2021-05-19 4/A FORM 4/A SUBMISSION 0001209191-21-034072 5533
2021-05-17 10-Q 10-Q 0001564590-21-028411 001-39386 21931170 34 5455190 1
2021-05-17 8-K 8-K 2.02,9.01 0001564590-21-028385 001-39386 21930610 34 220172
2021-05-11 4 FORM 4 SUBMISSION 0001209191-21-031638 10486
2021-05-05 4 FORM 4 SUBMISSION 0001209191-21-030336 5310
2021-05-05 3 FORM 3 SUBMISSION 0001209191-21-030326 5389
2021-05-04 8-K 8-K 5.02 0001564590-21-023431 001-39386 21890040 34 34594
2021-04-29 DEF 14A DEFINITIVE PROXY STATEMENT 0001193125-21-140336 001-39386 21870330 34 973260
2021-04-21 4 FORM 4 SUBMISSION 0000899243-21-016591 12523
2021-04-13 4 FORM 4 SUBMISSION 0000899243-21-015610 12534
2021-03-26 4 FORM 4 SUBMISSION 0000899243-21-013739 6900
2021-03-25 8-K 8-K PAO RESIGNATION 5.02 0001564590-21-015490 001-39386 21772503 34 29702
2021-03-24 4 FORM 4 SUBMISSION 0000899243-21-013283 20093
2021-03-18 S-8 S-8 0001193125-21-085943 333-254459 21755281 33 82198
2021-03-18 10-K 10-K 0001564590-21-014169 001-39386 21754660 34 13563020 1
2021-03-18 8-K 8-K 2.02,9.01 0001564590-21-014156 001-39386 21754453 34 323646
2021-03-15 8-K 8-K 5.02,9.01 0001193125-21-080594 001-39386 21739926 34 38222
2021-03-12 4 FORM 4 SUBMISSION 0000899243-21-011448 10490
2021-01-29 4 FORM 4 SUBMISSION 0000899243-21-003728 8482
2021-01-28 4 FORM 4 SUBMISSION 0000899243-21-003565 6900
2020-12-23 8-K 8-K 5.02 0001193125-20-325973 001-39386 201412314 34 17552
2020-12-15 4 FORM 4 SUBMISSION 0000899243-20-033928 6420
2020-12-11 424B4 424B4 0001193125-20-315060 333-251171 201381699 33 4740826
2020-12-09 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2020-12-09 16:30:00 9999999995-20-003466 333-251171 201379324 33 1690
2020-12-09 S-1MEF S-1MEF 0001193125-20-314133 333-251248 201379264 33 62392
2020-12-07 CORRESP filename1.htm 0001193125-20-311784 12573
2020-12-07 CORRESP filename1.htm 0001193125-20-311780 10928
2020-12-07 S-1 S-1 0001193125-20-311731 333-251171 201372740 33 11871305 1
2020-11-25 UPLOAD filename1.pdf 0000000000-20-011350 40438
2020-11-24 DRS filename1.htm 0000950123-20-012354 377-03819 201339719 33 4791564
2020-11-12 10-Q 10-Q 0001564590-20-053615 001-39386 201307368 34 7740745 1
2020-11-12 8-K 8-K 2.02,9.01 0001564590-20-053588 001-39386 201307010 34 273532
2020-10-01 SC 13D efc20-743_sc13d.htm 0000905148-20-001056 005-91585 201214737 34 355068
2020-08-27 10-Q 10-Q 0001564590-20-041556 001-39386 201143529 34 7989029 1
2020-08-27 8-K 8-K 2.02,9.01 0001564590-20-041538 001-39386 201143044 34 299776
2020-08-26 SC 13D alxo13d.htm 0000935836-20-000476 005-91585 201133834 34 92938
2020-07-31 SC 13D SC 13D 0001193125-20-204865 005-91585 201063491 34 244174
2020-07-29 SC 13G SCHEDULE 13G 0001213900-20-019061 005-91585 201057604 34 73170
2020-07-22 4 FORM 4 SUBMISSION 0000899243-20-020030 58317
2020-07-22 3/A FORM 3/A SUBMISSION 0000899243-20-020029 38288
2020-07-21 4 FORM 4 SUBMISSION 0000899243-20-019931 51045
2020-07-21 4 xslF345X03/form4.xml 0000905148-20-000827 35022
2020-07-21 4 FORM 4 SUBMISSION 0000899243-20-019915 16871
2020-07-21 4 FORM 4 SUBMISSION 0000899243-20-019913 10250
2020-07-21 4 FORM 4 SUBMISSION 0000899243-20-019912 4430
2020-07-21 4 FORM 4 SUBMISSION 0000899243-20-019911 32070
2020-07-21 4 FORM 4 SUBMISSION 0000899243-20-019910 4554
2020-07-21 4 FORM 4 SUBMISSION 0000899243-20-019908 4522
2020-07-21 4 FORM 4 SUBMISSION 0000899243-20-019906 7677
2020-07-21 4 FORM 4 SUBMISSION 0000899243-20-019904 12208
2020-07-21 8-K 8-K 5.03,7.01,9.01 0001193125-20-196288 001-39386 201038934 34 224132
2020-07-17 4 FORM 4 SUBMISSION 0000899243-20-019581 5459
2020-07-17 4 FORM 4 SUBMISSION 0000899243-20-019580 5240
2020-07-17 4 FORM 4 SUBMISSION 0000899243-20-019579 5262
2020-07-17 4 FORM 4 SUBMISSION 0000899243-20-019578 5292
2020-07-17 4 FORM 4 SUBMISSION 0000899243-20-019577 5340
2020-07-17 4 FORM 4 SUBMISSION 0000899243-20-019576 5346
2020-07-17 4 FORM 4 SUBMISSION 0000899243-20-019575 5314
2020-07-17 4 FORM 4 SUBMISSION 0000899243-20-019573 5335
2020-07-17 4 FORM 4 SUBMISSION 0000899243-20-019572 5330
2020-07-17 S-8 S-8 0001193125-20-194772 333-239927 201034169 33 92333
2020-07-17 424B4 424B4 0001193125-20-194755 333-239490 201034039 33 4100658
2020-07-16 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2020-07-16 16:00:00 9999999995-20-001829 333-239490 201032685 33 1690
2020-07-16 3 FORM 3 SUBMISSION 0000899243-20-019470 36849
2020-07-16 S-1MEF S-1MEF 0001193125-20-194168 333-239895 201032508 33 60926
2020-07-16 3 xslF345X02/form3.xml 0000905148-20-000817 22913
2020-07-16 3 FORM 3 SUBMISSION 0000899243-20-019409 6708

Latest XBRL company facts

One latest value per concept from companyfacts (309 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 129.27M 2026-11-09 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
dei EntityPublicFloat Entity Public Float USD 18.00M 2025-06-30 2025 FY 10-K 2026-03-09 0001193125-26-098454
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 836,184 2025-01-01 2025-12-31 DEF 14A 2026-04-20 0001193125-26-163936
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 1.20M 2025-01-01 2025-12-31 DEF 14A 2026-04-20 0001193125-26-163936
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 10.03 2025-01-01 2025-12-31 DEF 14A 2026-04-20 0001193125-26-163936
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 3.99M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 815,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 15.03M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 797,000 2023-03-31 2023 Q1 10-Q 2023-05-11 0000950170-23-021247
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 981,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -259,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 906.51M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 2.89M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 8.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 168,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 15.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 3.17M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap Assets Assets USD 154.67M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap AssetsCurrent Assets, Current USD 152.87M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Assets, Current USD 641,000 2020-06-30 2020 Q2 10-Q 2020-08-27 0001564590-20-041556
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 123.50M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 123.50M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 1.38M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0000950170-23-062929
us-gaap Cash Cash USD 23.70M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 35.45M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 35.65M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 19.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 9.497 2020-08-17 2020 FY 10-K 2021-03-18 0001564590-21-014169
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 61,292 2020-08-17 2020 FY 10-K 2021-03-18 0001564590-21-014169
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 34.11M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 1.00B 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 142.63M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 142.63M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap CommonStockValue Common Stock, Value, Issued USD 143,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -58.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap ContractualObligation Contractual Obligation USD 860,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap ContractualObligationDueInFourthAndFifthYear Contractual Obligation, to be Paid, Year Four and Five USD 50,000 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-123290
us-gaap ContractualObligationDueInNextTwelveMonths Contractual Obligation, to be Paid, Year One USD 860,000 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap ContractualObligationDueInSecondAndThirdYear Contractual Obligation, to be Paid, Year Two and Three USD 437,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear Contractual Obligation, to be Paid, Remainder of Fiscal Year USD 423,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 175.04M 2020-01-01 2020-12-31 2022 FY 10-K 2023-03-09 0000950170-23-007013
us-gaap CostsAndExpensesRelatedParty Costs and Expenses, Related Party USD 1.07M 2020-01-01 2020-12-31 2022 FY 10-K 2023-03-09 0000950170-23-007013
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 6.00M 2020-09-30 2020 Q3 10-Q 2020-11-12 0001564590-20-053615
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 419,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD 240,000 2020-09-30 2020 Q3 10-Q 2020-11-12 0001564590-20-053615
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 311,000 2020-01-01 2020-03-31 2021 Q1 10-Q 2021-05-17 0001564590-21-028411
us-gaap DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss USD 700,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLoss Debt Securities, Available-for-sale, Allowance for Credit Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss USD 0 2022-03-31 2022 Q1 10-Q 2022-05-09 0000950170-22-008499
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 561,000 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 2.41M 2020-06-30 2020 Q2 10-Q 2020-08-27 0001564590-20-041556
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 135,000 2019-12-31 2020 Q2 10-Q 2020-08-27 0001564590-20-041556
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 26.97M 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 150.24M 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 71.14M 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 5.92M 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 266,000 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 149.68M 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap DeferredTaxLiabilitiesPrepaidExpenses Deferred Tax Liabilities, Prepaid Expenses USD 252,000 2022-12-31 2023 FY 10-K 2024-03-07 0000950170-24-027955
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 144,000 2023-03-31 2023 Q1 10-Q 2023-05-11 0000950170-23-021247
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 300,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 292,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap DueFromRelatedPartiesCurrent Due from Related Parties, Current USD 536,000 2019-12-31 2020 FY 10-K 2021-03-18 0001564590-21-014169
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 830,000 2023-03-31 2023 Q1 10-Q 2023-05-11 0000950170-23-021247
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.45 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.6 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-09 0000950170-22-008499
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.45 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.188 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount USD -74,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent pure 0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.006 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.04 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.024 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 3.82M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 12.60M 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 0 2021-12-31 2021 FY 10-K 2022-02-28 0001564590-22-007364
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 8,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-02-28 0001564590-22-007364
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 0 2022-03-31 2022 Q1 10-Q 2022-05-09 0000950170-22-008499
us-gaap FairValueAssetsLevel2ToLevel1TransfersAmount Fair Value, Assets, Level 2 to Level 1 Transfers, Amount USD 0 2022-03-31 2022 Q1 10-Q 2022-05-09 0000950170-22-008499
us-gaap FairValueLiabilitiesLevel1ToLevel2TransfersAmount Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount USD 0 2022-03-31 2022 Q1 10-Q 2022-05-09 0000950170-22-008499
us-gaap FairValueLiabilitiesLevel2ToLevel1TransfersAmount Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount USD 0 2022-03-31 2022 Q1 10-Q 2022-05-09 0000950170-22-008499
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap FederalIncomeTaxExpenseBenefitContinuingOperations Federal Income Tax Expense (Benefit), Continuing Operations USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 79,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap FinanceLeaseInterestPaymentOnLiability Finance Lease, Interest Payment on Liability USD 97,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 847,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 847,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 880,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap FinanceLeaseLiabilityPaymentsDueInNextRollingTwelveMonths Finance Lease, Liability, Payments, Due in Next Rolling Twelve Months USD 616,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap FinanceLeaseLiabilityPaymentsDueInRollingYearThree Finance Lease, Liability, Payments, Due in Rolling Year Three USD 616,000 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034761
us-gaap FinanceLeaseLiabilityPaymentsDueInRollingYearTwo Finance Lease, Liability, Payments, Due in Rolling Year Two USD 616,000 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 432,000 2021-12-31 2021 FY 10-K 2022-02-28 0001564590-22-007364
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 264,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 33,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 783,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 796,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 717,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.085 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap ForeignIncomeTaxExpenseBenefitContinuingOperations Foreign Income Tax Expense (Benefit), Continuing Operations USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -246,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -904,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 15.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap ImpairmentOfInvestments Other than Temporary Impairment Losses, Investments USD 0 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-09 0000950170-24-056953
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 3.20M 2025-04-01 2025-06-30 2026 Q1 10-Q 2026-05-08 0001193125-26-213399
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -101.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -101.69M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -497,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap IncomeLossFromContinuingOperationsPerBasicAndDilutedShare Income (Loss) from Continuing Operations, Per Basic and Diluted Share USD/shares -0.6 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-09 0000950170-22-008499
us-gaap IncomeLossFromContinuingOperationsPerBasicShare Income (Loss) from Continuing Operations, Per Basic Share USD/shares -3.03 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-007013
us-gaap IncomeLossFromContinuingOperationsPerDilutedShare Income (Loss) from Continuing Operations, Per Diluted Share USD/shares -3.03 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-007013
us-gaap IncomeTaxesPaid Income Taxes Paid USD 274,000 2021-01-01 2021-12-31 2023 FY 10-K 2024-03-07 0000950170-24-027955
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 19.16M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 104,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -21.36M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 585,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 4.03M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap IncomeTaxReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount USD 1.10M 2021-01-01 2021-12-31 2023 FY 10-K 2024-03-07 0000950170-24-027955
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 2.44M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -925,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap IncreaseDecreaseInDeferredLiabilities Increase (Decrease) in Deferred Liabilities USD -135,000 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-27 0001564590-20-041556
us-gaap IncreaseDecreaseInDueFromRelatedPartiesCurrent Increase (Decrease) in Due from Related Parties, Current USD -536,000 2020-01-01 2020-12-31 2022 FY 10-K 2023-03-09 0000950170-23-007013
us-gaap IncreaseDecreaseInOtherAccruedLiabilities Increase (Decrease) in Other Accrued Liabilities USD 2.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD -821,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -376,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -301,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap InterestExpense Interest Expense USD 841,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap InterestExpenseDebt Interest Expense, Debt USD 700,000 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-12 0001564590-20-053615
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 4.28M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-007013
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 1.26M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap InterestReceivableNoncurrent Interest Receivable, Noncurrent USD 182,000 2023-03-31 2023 Q1 10-Q 2023-05-11 0000950170-23-021247
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 4.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap LeaseCost Lease, Cost USD 1.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.1 2025-09-30 2025 Q3 10-Q 2025-11-07 0001193125-25-272281
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 114,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive Lessee, Operating Lease, Liability, Payments, Due after Rolling Year Five USD 163,000 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034761
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Five USD 163,000 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four USD 163,000 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-213399
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three USD 967,000 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-213399
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two USD 939,000 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-213399
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months USD 57,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 519,000 2021-12-31 2021 FY 10-K 2022-02-28 0001564590-22-007364
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 247,000 2020-06-30 2020 Q2 10-Q 2020-08-27 0001564590-20-041556
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 577,000 2020-06-30 2020 Q2 10-Q 2020-08-27 0001564590-20-041556
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 57,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 1,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap Liabilities Liabilities USD 28.82M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 154.67M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap LiabilitiesCurrent Liabilities, Current USD 19.02M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap LongTermDebt Long-term Debt USD 10.20M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap LongTermDebtMaturingInYearsTwoAndThree Long-Term Debt, Maturity, Year Two and Three USD 6.75M 2020-09-30 2020 Q3 10-Q 2020-11-12 0001564590-20-053615
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 4.95M 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-213399
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 4.95M 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-007013
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 2.70M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 5.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 2.50M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 3.91M 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-213399
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 9.74M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap LongTermInvestments Long-term Investments USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 147.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -79.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -49.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -57.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -123.48M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-007013
us-gaap NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 Noncash or Part Noncash Acquisition, Fixed Assets Acquired USD 1.01M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1 Noncash or Part Noncash Acquisition, Value of Assets Acquired USD 482,000 2021-01-01 2021-12-31 2023 FY 10-K 2024-03-07 0000950170-24-027955
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-213399
us-gaap OperatingExpenses Operating Expenses USD 59.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -59.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap OperatingLeaseCost Operating Lease, Cost USD 452,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 600,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-18 0001564590-21-014169
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 113,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 113,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap OperatingLeasePayments Operating Lease, Payments USD 652,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 148,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 346,000 2020-12-31 2021 FY 10-K 2022-02-28 0001564590-22-007364
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoAndThreeYears Operating Leases, Future Minimum Payments, Due in Two and Three Years USD 206,000 2020-12-31 2021 FY 10-K 2022-02-28 0001564590-22-007364
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 140,000 2020-12-31 2021 FY 10-K 2022-02-28 0001564590-22-007364
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.037 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 1.32M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap OtherAssetsCurrent Other Assets, Current USD 132,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 1.66M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -287,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap OtherGeneralAndAdministrativeExpense Other General and Administrative Expense USD 5.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 64,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 404,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-18 0001564590-21-014169
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -103,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 2.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 6,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-18 0001564590-21-014169
us-gaap PaymentsOfDebtExtinguishmentCosts Payment for Debt Extinguishment or Debt Prepayment Cost USD 8.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 298,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 627,000 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap PaymentsToAcquireInProcessResearchAndDevelopment Payments to Acquire in Process Research and Development USD 4.26M 2021-01-01 2021-12-31 2023 FY 10-K 2024-03-07 0000950170-24-027955
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 155.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 132,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap PreferredStockDividendsAndOtherAdjustments Preferred Stock Dividends and Other Adjustments USD 5.20M 2020-01-01 2020-12-31 2022 FY 10-K 2023-03-09 0000950170-23-007013
us-gaap PreferredStockDividendsIncomeStatementImpact Preferred Stock Dividends, Income Statement Impact USD 5.20M 2020-01-01 2020-12-31 2022 FY 10-K 2023-03-09 0000950170-23-007013
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2020-07-21 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 100.00M 2021-03-31 2021 Q1 10-Q 2021-05-17 0001564590-21-028411
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2021-03-31 2021 Q1 10-Q 2021-05-17 0001564590-21-028411
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2021-03-31 2021 Q1 10-Q 2021-05-17 0001564590-21-028411
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 5.66M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 998,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap PrepaidInsurance Prepaid Insurance USD 681,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 8.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 104.68M 2020-01-01 2020-12-31 2022 FY 10-K 2023-03-09 0000950170-23-007013
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 10.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap ProceedsFromOtherEquity Proceeds from Other Equity USD 150.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap ProceedsFromSaleMaturityAndCollectionsOfInvestments Proceeds from Sale, Maturity and Collection of Investments USD 234.07M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0000950170-23-062929
us-gaap ProceedsFromSaleOfAvailableForSaleSecuritiesDebt Proceeds from Sale of Debt Securities, Available-for-sale USD 75.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap ProceedsFromSaleOfPropertyHeldForSale Proceeds from Sale of Property Held-for-sale USD 641,000 2020-01-01 2020-12-31 2022 FY 10-K 2023-03-09 0000950170-23-007013
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 173,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 835,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 31,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 6,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -57.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 1.13M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 149,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap PurchaseObligation Purchase Obligation USD 860,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap PurchaseObligationDueInFourthAndFifthYear Purchase Obligation, to be Paid, Year Four and Five USD 50,000 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-123290
us-gaap PurchaseObligationDueInNextTwelveMonths Purchase Obligation, to be Paid, Year One USD 860,000 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap PurchaseObligationDueInSecondAndThirdYear Purchase Obligation, to be Paid, Year Two and Three USD 437,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap PurchaseObligationDueInSecondYear Purchase Obligation, to be Paid, Year Two USD 298,000 2020-06-30 2020 Q2 10-Q 2020-08-27 0001564590-20-041556
us-gaap PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear Purchase Obligation, to be Paid, Remainder of Fiscal Year USD 423,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap RepaymentsOfDebt Repayments of Debt USD 2.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 44.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 4.74M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-09 0000950170-23-007013
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 66,000 2026-06-30 2026 Q2 10-Q 2026-08-06 0001193125-26-337920
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 200,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 66,000 2023-03-31 2023 Q1 10-Q 2023-05-11 0000950170-23-021247
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -780.54M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0000950170-23-007013
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 1.03M 2024-01-01 2024-06-30 2025 Q2 10-Q 2025-08-12 0000950170-25-107303
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 168,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 8.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding USD 49.74M 2021-12-31 2021 FY 10-K 2022-02-28 0001564590-22-007364
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.993 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.939 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.047 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.036 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 3.41M 2021-12-31 2021 FY 10-K 2022-02-28 0001564590-22-007364
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 6.09M 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 10.56 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 5.03M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 7.39M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.07 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 830,000 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 12.88M 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 6.06 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 31,000 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 1.01 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 7.51 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 1.37 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap ShortTermInvestments Short-term Investments USD 111.75M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 89,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap StateAndLocalIncomeTaxExpenseBenefitContinuingOperations State and Local Income Tax Expense (Benefit), Continuing Operations USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 125.85M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.152 2020-07-08 2022 FY 10-K 2023-03-09 0000950170-23-007013
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 14,146 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 175.04M 2020-01-01 2020-12-31 2022 FY 10-K 2023-03-09 0000950170-23-007013
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 31,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 364.40M 2020-01-01 2020-12-31 2022 FY 10-K 2023-03-09 0000950170-23-007013
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 92,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap SubleaseIncome Sublease Income USD 2.50M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-07 0001193125-25-272281
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 70.36M 2019-12-31 2020 FY 10-K 2021-03-18 0001564590-21-014169
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 83.58M 2019-12-31 2020 FY 10-K 2021-03-18 0001564590-21-014169
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 11.57M 2019-12-31 2020 FY 10-K 2021-03-18 0001564590-21-014169
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 4.73M 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 620,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities Unrecognized Tax Benefits, Increase Resulting from Settlements with Taxing Authorities USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 20.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-098454
us-gaap WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount Warrant, Down Round Feature, (Increase) Decrease in Equity, Amount USD -1.02M 2020-01-01 2020-12-31 2021 FY 10-K 2022-02-28 0001564590-22-007364
us-gaap WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1 WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1 USD 1.02M 2020-01-01 2020-12-31 2022 FY 10-K 2023-03-09 0000950170-23-007013
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 127.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 40.62M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-09 0000950170-22-008499
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 127.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462197

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →